No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / standards
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bleomycin / administration & dosage
-
Bleomycin / adverse effects
-
Bleomycin / standards
-
Cisplatin / administration & dosage
-
Cisplatin / adverse effects
-
Cisplatin / standards
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Cyclophosphamide / standards
-
Dactinomycin / administration & dosage
-
Dactinomycin / adverse effects
-
Dactinomycin / standards
-
Etoposide / administration & dosage
-
Etoposide / adverse effects
-
Etoposide / standards
-
Female
-
Fertility / drug effects
-
Humans
-
Neoplasms, Germ Cell and Embryonal / drug therapy
-
Neoplasms, Germ Cell and Embryonal / surgery
-
Neoplasms, Germ Cell and Embryonal / therapy*
-
Ovarian Neoplasms / drug therapy
-
Ovarian Neoplasms / surgery
-
Ovarian Neoplasms / therapy*
-
Salvage Therapy
-
Vinblastine / administration & dosage
-
Vinblastine / adverse effects
-
Vinblastine / standards
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
-
Vincristine / standards
Substances
-
Bleomycin
-
Dactinomycin
-
Vincristine
-
Vinblastine
-
Etoposide
-
Cyclophosphamide
-
Cisplatin
Supplementary concepts
-
BEP protocol
-
PVB protocol
-
VAC protocol